1. Home
  2. Companies
  3. Wavemaker Three-Sixty Health
Wavemaker Three-Sixty Health logoWT

Wavemaker Three-Sixty Health

About

What differentiates Wavemaker 360 the most is the fact that the majority of our investors come from the healthcare industry. We think of them as our company's lifeguards, providing all sorts of support and services to our portfolio companies.

Wavemaker 360’s Limited Partners include healthcare corporates, family offices with healthcare backgrounds, and more than 100 individual investors that have spent their career in the healthcare industry.

Collectively this group of investors is our secret weapon and superpower - they are willing and able to commercially support the companies we invest into. In fact, for many of them, getting more connectivity to healthcare innovation is a primary reason they are involved with Wavemaker 360.

These Limited Partners combine to make Wavemaker 360 the most strategic healthcare-focused venture fund in the US and give the fund an “unfair advantage” when it comes to sourcing high quality investment opportunities, evaluating early-stage companies, and providing commercial support post-investment.

Similar companies

SpringTide Ventures logoSV

SpringTide Ventures

Venture capital for tomorrow’s greatest healthcare companies.

LRVHealth logoLR

LRVHealth

The healthcare venture capital platform connecting the largest strategic network of leading healthcare organizations with the entrepreneurs addressing the industry's biggest challenges and opportunities.

Inflect Capital logoIC

Inflect Capital

We invest, incubate, and advise companies to transform the future of healthcare.

HC9 Ventures logoHV

HC9 Ventures

HC9 Ventures is an early-stage healthcare venture capital firm built to provide deep industry expertise to emerging companies.

Abundant Venture Partners logoAV

Abundant Venture Partners

We grow high value, sustainable companies that benefit healthcare providers.

Gilmartin Capital logoGC

Gilmartin Capital

We invest in entrepreneurs targeting platforms that influence large or underserved diseases, technologies that accelerate and expand scientific discovery, and solutions that impact the cost, site and delivery of care.